ZOLADEX BREAST CANCER APPROVAL ADDS NEW INDICATION TO ZENECA's FASTEST GROWING MAJOR PRODUCT; PHASE IV STUDY TO COME ON RELATIONSHIP OF DRUG TO ESTRADIOL